Check out this broad range of innovative medications in development with the goal of providing psychiatric clinicians with novel treatments in the quest to decrease patient suffering and improve function and quality of life.
Neumora Therapeutics (NASDAQ:NMRA) Sees Strong Trading Volume theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) was up 3.5% on Tuesday . The company traded as high as $16.24 and last traded at $16.24. Approximately 14,677 shares were traded during mid-day trading, a decline of 92% from the average daily volume of 176,717 shares. The stock had previously closed at $15.69. Analysts Set […]
Investor interest in newly-issued biotech stocks has been moribund for years, but the sector’s first IPO of 2024, CG Oncology, suggests that investors might.